Effectiveness of Quetiapine XR on the Control of Symptoms of Manic Phase of Bipolar Disorder.

PHASE4CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
Bipolar DisorderBipolar Affective PsychosisManiaManic DisorderManic State
Interventions
DRUG

Quetiapine 600mg

"300 mg quetiapine fumarate tablets for oral use.~Day 1: One 300 mg tablet in the evening Day 2: Two 300 mg tablet in the evening Day 3 and onwards: Two 300 mg tablets in the evening, efforts must be done to maintain a daily dose of 600 mg/day."

Trial Locations (7)

Unknown

Research Site, Guadalajara

Research Site, Mexico City

Research Site, Monterrey

Research Site, San Pedro Garza García

Research Site, San Luis Potosí City

Research Site, Mérida

Research Site, Durango

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY